Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
454.6 GBX | +2.85% | +2.30% | -6.65% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 19 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company is one of the best yield companies with high dividend expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Employment Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.65% | 1.79B | B- | ||
-10.35% | 1.94B | B- | ||
+9.52% | 655M | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MPI Stock
- Ratings PageGroup plc